Want to see AU:EYE full AI Analyst Report?
Total Valuation
Nova Eye Medical has a market cap or net worth of AU$37.04M. The enterprise value is AU$31.34M.
Market CapAU$37.04M
Enterprise ValueAU$31.34M
Share Statistics
Nova Eye Medical has 284,921,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding284,921,080
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nova Eye Medical’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -26.25%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)-0.20
Return on Invested Capital (ROIC)-26.25%
Return on Capital Employed (ROCE)-0.27
Revenue Per Employee115.83K
Profits Per Employee-14.40K
Employee Count301
Asset Turnover1.62
Inventory Turnover3.04
Valuation Ratios
The current PE Ratio of Nova Eye Medical is ―. Nova Eye Medical’s PEG ratio is 0.12.
PE Ratio―
PS Ratio0.86
PB Ratio2.09
Price to Fair Value2.09
Price to FCF-8.90
Price to Operating Cash Flow-11.86
PEG Ratio0.12
Income Statement
In the last 12 months, Nova Eye Medical had revenue of 34.87M and earned -4.33M in profits. Earnings per share was -0.02.
Revenue34.87M
Gross Profit25.01M
Operating Income-4.38M
Pretax Income-4.33M
Net Income-4.33M
EBITDA-2.21M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -3.12M and capital expenditures -235.00K, giving a free cash flow of -3.36M billion.
Operating Cash Flow-3.12M
Free Cash Flow-3.36M
Free Cash Flow per Share-0.01
Dividends & Yields
Nova Eye Medical pays an annual dividend of AU$0.414, resulting in a dividend yield of 185.34%
Dividend Per ShareAU$0.414
Dividend Yield185.34%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.77
52-Week Price Change-16.13%
50-Day Moving Average0.14
200-Day Moving Average0.14
Relative Strength Index (RSI)44.96
Average Volume (3m)176.86K
Important Dates
Nova Eye Medical upcoming earnings date is Mar 2, 2027, TBA (Confirmed).
Last Earnings DateAug 26, 2026
Next Earnings DateMar 2, 2027
Ex-Dividend Date―
Financial Position
Nova Eye Medical as a current ratio of 1.74, with Debt / Equity ratio of 16.77%
Current Ratio1.74
Quick Ratio1.15
Debt to Market Cap0.02
Net Debt to EBITDA-0.65
Interest Coverage Ratio-28.41
Taxes
In the past 12 months, Nova Eye Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Nova Eye Medical EV to EBITDA ratio is -14.18, with an EV/FCF ratio of -9.32.
EV to Sales0.90
EV to EBITDA-14.18
EV to Free Cash Flow-9.32
EV to Operating Cash Flow-10.03
Balance Sheet
Nova Eye Medical has AU$964.00K in cash and marketable securities with AU$2.39M in debt, giving a net cash position of -AU$1.43M billion.
Cash & Marketable SecuritiesAU$964.00K
Total DebtAU$2.39M
Net Cash-AU$1.43M
Net Cash Per Share>-AU$0.01
Tangible Book Value Per ShareAU$0.02
Margins
Gross margin is 71.74%, with operating margin of -12.55%, and net profit margin of -12.43%.
Gross Margin71.74%
Operating Margin-12.55%
Pretax Margin-12.43%
Net Profit Margin-12.43%
EBITDA Margin-6.33%
EBIT Margin-12.55%
Analyst Forecast
The average price target for Nova Eye Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast19.13%
EPS Growth Forecast58.47%